Search - tctmd.com

Displaying 861 - 880 of 1322

Sort: Relevancy | Date

News Conference News ACC 2016

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

April 02, 2016

News Conference News ACC 2016

HOPE-3: Reducing LDL Cholesterol Improves Outcomes in Intermediate-Risk Patients, but BP-Lowering Does Not

Michael O'Riordan

April 02, 2016

News Daily News

ACC Updates LDL-Cholesterol Lowering Recommendations, Making Room for Ezetimibe and PCSK9 Inhibitors

Michael O'Riordan

April 02, 2016

News Daily News

ACC actualiza las recomendaciones para bajar el colesterol LBD, abriendo un espacio para el uso de Ezetimibe y de los inhibidores de PCSK9

Michael O'Riordan

April 02, 2016

News Daily News

La Activación del Centro de Estrés Cerebral Podría Provocar Inflamación y Episodios Cardiovasculares

March 28, 2016

News Daily News

Activation of Brain’s Stress Center May Spur Inflammation, Cardiovascular Events

March 28, 2016

News Daily News

越来越多证据显示以肠促胰岛素类降糖药不会增加心衰风险

Michael O'Riordan

March 25, 2016

News Daily News

Evidence Mounts Showing No Increased Risk of Heart Failure With Incretin-Based Antidiabetic Drugs

Michael O'Riordan

March 25, 2016

News Daily News

Cada Vez Más Evidencias Confirman que No hay un Mayor Riesgo de Insuficiencia Cardíaca asociado a los Fármacos Antidiabéticos basados en la Incretina

Michael O'Riordan

March 25, 2016

News Daily News

Se Observa un ‘Tímido Aumento Clínico’ del Riesgo de Mortalidad en Nonagenarios sometidos a TAVR

March 23, 2016

News Daily News

UK Data Link a Physically Active Commute to Lower BMI in Middle-Aged People

March 17, 2016

News Daily News

Una Calculadora Estima el Riesgo de IM Espontáneo en Pacientes Víctimas de SCASEST Tratados Médicamente

March 16, 2016

News Daily News

Calculator Estimates Spontaneous MI Risk in Medically Managed NSTE ACS Patients

March 16, 2016

News Daily News

Controversial LIGHT Trial Now Published but Fails to Illuminate CV Risks of Contrave

Michael O'Riordan

March 08, 2016

News Industry News

Victoza® Significantly Reduced the Risk of Major Adverse Cardiovascular Events in the LEADER Trial

March 06, 2016

News Industry News

New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control

March 01, 2016

News Daily News

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

February 23, 2016

News Daily News

Los Resultados de la Válvula Aórtica Transcatéter son Mejores en Mujeres que en Hombres a los 12 Meses

February 23, 2016

News Daily News

Anxiety a Marker of Exercise-Induced Ischemia in Women but Not Men

February 23, 2016

News Conference News CRT 2016

STEMI Mortality Risk Doubled in Women, Even in North America, Europe

February 20, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.